Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | serotonin transporter | 0.0396 | 0.4231 | 0.4231 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0396 | 0.4231 | 1 |
Onchocerca volvulus | 0.0396 | 0.4231 | 1 | |
Trypanosoma brucei | inositol 1,4,5-trisphosphate receptor | 0.009 | 0 | 0.5 |
Echinococcus multilocularis | serotonin receptor | 0.0813 | 1 | 1 |
Loa Loa (eye worm) | serotonin transporter b | 0.0396 | 0.4231 | 0.4231 |
Loa Loa (eye worm) | hypothetical protein | 0.0396 | 0.4231 | 0.4231 |
Schistosoma mansoni | transient receptor potential channel | 0.009 | 0.00000064045 | 0.00000064045 |
Echinococcus multilocularis | serotonin transporter | 0.0396 | 0.4231 | 0.4231 |
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.0396 | 0.4231 | 0.4231 |
Loa Loa (eye worm) | hypothetical protein | 0.009 | 0.00000064045 | 0.00000064045 |
Leishmania major | hypothetical protein, unknown function | 0.009 | 0 | 0.5 |
Toxoplasma gondii | transporter, cation channel family protein | 0.009 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0396 | 0.4231 | 0.4231 |
Echinococcus multilocularis | transient receptor potential cation channel | 0.009 | 0.00000064045 | 0.00000064045 |
Echinococcus granulosus | transient receptor potential cation channel | 0.009 | 0.00000064045 | 0.00000064045 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.009 | 0 | 0.5 |
Brugia malayi | olfactory channel protein osm-9 | 0.009 | 0.00000064045 | 0.0000015137 |
Toxoplasma gondii | hypothetical protein | 0.009 | 0 | 0.5 |
Echinococcus granulosus | transient receptor potential cation channel | 0.009 | 0.00000064045 | 0.00000064045 |
Echinococcus multilocularis | serotonin receptor | 0.0813 | 1 | 1 |
Echinococcus multilocularis | transient receptor potential cation channel | 0.009 | 0.00000064045 | 0.00000064045 |
Trypanosoma brucei | Voltage-dependent calcium channel subunit, putative | 0.009 | 0 | 0.5 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.009 | 0 | 0.5 |
Trypanosoma cruzi | Voltage-dependent calcium channel subunit, putative | 0.009 | 0 | 0.5 |
Loa Loa (eye worm) | solute carrier family 6 member 4 | 0.0396 | 0.4231 | 0.4231 |
Loa Loa (eye worm) | hypothetical protein | 0.0813 | 1 | 1 |
Toxoplasma gondii | hypothetical protein | 0.009 | 0 | 0.5 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0813 | 1 | 1 |
Leishmania major | calcium channel protein, putative,ion transporter, putative | 0.009 | 0 | 0.5 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.009 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.009 | 0 | 0.5 |
Treponema pallidum | sodium- and chloride- dependent transporter | 0.0396 | 0.4231 | 0.5 |
Toxoplasma gondii | transporter, cation channel family protein | 0.009 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.009 | 0.00000064045 | 0.00000064045 |
Loa Loa (eye worm) | hypothetical protein | 0.009 | 0.00000064045 | 0.00000064045 |
Echinococcus granulosus | transient receptor potential cation channel | 0.009 | 0.00000064045 | 0.00000064045 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.009 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0813 | 1 | 1 |
Loa Loa (eye worm) | norepinephrine transporter | 0.0396 | 0.4231 | 0.4231 |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.0396 | 0.4231 | 0.4231 |
Trypanosoma cruzi | inositol 1,4,5-trisphosphate receptor, putative | 0.009 | 0 | 0.5 |
Echinococcus multilocularis | transient receptor potential cation channel | 0.009 | 0.00000064045 | 0.00000064045 |
Loa Loa (eye worm) | hypothetical protein | 0.0396 | 0.4231 | 0.4231 |
Toxoplasma gondii | transporter, cation channel family protein | 0.009 | 0 | 0.5 |
Schistosoma mansoni | transient receptor potential channel | 0.009 | 0.00000064045 | 0.00000064045 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.